BRENDA - Enzyme Database show
show all sequences of 2.7.1.60

Cloning, expression, purification, crystallization and preliminary X-ray diffraction analysis of N-acetylmannosamine kinase from methicillin-resistant Staphylococcus aureus

North, R.A.; Seizova, S.; Stampfli, A.; Kessans, S.A.; Suzuki, H.; Griffin, M.D.; Kvansakul, M.; Dobson, R.C.; Acta Crystallogr. Sect. F 70, 643-649 (2014)

Data extracted from this reference:

Cloned(Commentary)
Commentary
Organism
expressed in Escherichia coli BL21(DE3) cells
Staphylococcus aureus
Crystallization (Commentary)
Crystallization
Organism
sitting drop vapor diffusion method, using 0.2 M ammonium chloride, 20% (w/v) polyethylene glycol 6000, 0.1 M HEPES pH 7.0
Staphylococcus aureus
Molecular Weight [Da]
Molecular Weight [Da]
Molecular Weight Maximum [Da]
Commentary
Organism
35000
-
x * 35000, SDS-PAGE
Staphylococcus aureus
Natural Substrates/ Products (Substrates)
Natural Substrates
Organism
Commentary (Nat. Sub.)
Natural Products
Commentary (Nat. Pro.)
Organism (Nat. Pro.)
Reversibility
ATP + N-acyl-D-mannosamine
Staphylococcus aureus
-
ADP + N-acyl-D-mannosamine 6-phosphate
-
-
?
ATP + N-acyl-D-mannosamine
Staphylococcus aureus USA300
-
ADP + N-acyl-D-mannosamine 6-phosphate
-
-
?
Organism
Organism
Primary Accession No. (UniProt)
Commentary
Textmining
Staphylococcus aureus
-
-
-
Staphylococcus aureus USA300
-
-
-
Purification (Commentary)
Commentary
Organism
Q Sepharose column chromatography, phenyl Sepharose column chromatography, and Superdex 200 gel filtration
Staphylococcus aureus
Substrates and Products (Substrate)
Substrates
Commentary Substrates
Literature (Substrates)
Organism
Products
Commentary (Products)
Literature (Products)
Organism (Products)
Reversibility
ATP + N-acyl-D-mannosamine
-
737385
Staphylococcus aureus
ADP + N-acyl-D-mannosamine 6-phosphate
-
-
-
?
ATP + N-acyl-D-mannosamine
-
737385
Staphylococcus aureus USA300
ADP + N-acyl-D-mannosamine 6-phosphate
-
-
-
?
Subunits
Subunits
Commentary
Organism
?
x * 35000, SDS-PAGE
Staphylococcus aureus
Cloned(Commentary) (protein specific)
Commentary
Organism
expressed in Escherichia coli BL21(DE3) cells
Staphylococcus aureus
Crystallization (Commentary) (protein specific)
Crystallization
Organism
sitting drop vapor diffusion method, using 0.2 M ammonium chloride, 20% (w/v) polyethylene glycol 6000, 0.1 M HEPES pH 7.0
Staphylococcus aureus
Molecular Weight [Da] (protein specific)
Molecular Weight [Da]
Molecular Weight Maximum [Da]
Commentary
Organism
35000
-
x * 35000, SDS-PAGE
Staphylococcus aureus
Natural Substrates/ Products (Substrates) (protein specific)
Natural Substrates
Organism
Commentary (Nat. Sub.)
Natural Products
Commentary (Nat. Pro.)
Organism (Nat. Pro.)
Reversibility
ATP + N-acyl-D-mannosamine
Staphylococcus aureus
-
ADP + N-acyl-D-mannosamine 6-phosphate
-
-
?
ATP + N-acyl-D-mannosamine
Staphylococcus aureus USA300
-
ADP + N-acyl-D-mannosamine 6-phosphate
-
-
?
Purification (Commentary) (protein specific)
Commentary
Organism
Q Sepharose column chromatography, phenyl Sepharose column chromatography, and Superdex 200 gel filtration
Staphylococcus aureus
Substrates and Products (Substrate) (protein specific)
Substrates
Commentary Substrates
Literature (Substrates)
Organism
Products
Commentary (Products)
Literature (Products)
Organism (Products)
Reversibility
ATP + N-acyl-D-mannosamine
-
737385
Staphylococcus aureus
ADP + N-acyl-D-mannosamine 6-phosphate
-
-
-
?
ATP + N-acyl-D-mannosamine
-
737385
Staphylococcus aureus USA300
ADP + N-acyl-D-mannosamine 6-phosphate
-
-
-
?
Subunits (protein specific)
Subunits
Commentary
Organism
?
x * 35000, SDS-PAGE
Staphylococcus aureus
Other publictions for EC 2.7.1.60
No.
1st author
Pub Med
title
organims
journal
volume
pages
year
Activating Compound
Application
Cloned(Commentary)
Crystallization (Commentary)
Engineering
General Stability
Inhibitors
KM Value [mM]
Localization
Metals/Ions
Molecular Weight [Da]
Natural Substrates/ Products (Substrates)
Organic Solvent Stability
Organism
Oxidation Stability
Posttranslational Modification
Purification (Commentary)
Reaction
Renatured (Commentary)
Source Tissue
Specific Activity [micromol/min/mg]
Storage Stability
Substrates and Products (Substrate)
Subunits
Temperature Optimum [°C]
Temperature Range [°C]
Temperature Stability [°C]
Turnover Number [1/s]
pH Optimum
pH Range
pH Stability
Cofactor
Ki Value [mM]
pI Value
IC50 Value
Activating Compound (protein specific)
Application (protein specific)
Cloned(Commentary) (protein specific)
Cofactor (protein specific)
Crystallization (Commentary) (protein specific)
Engineering (protein specific)
General Stability (protein specific)
IC50 Value (protein specific)
Inhibitors (protein specific)
Ki Value [mM] (protein specific)
KM Value [mM] (protein specific)
Localization (protein specific)
Metals/Ions (protein specific)
Molecular Weight [Da] (protein specific)
Natural Substrates/ Products (Substrates) (protein specific)
Organic Solvent Stability (protein specific)
Oxidation Stability (protein specific)
Posttranslational Modification (protein specific)
Purification (Commentary) (protein specific)
Renatured (Commentary) (protein specific)
Source Tissue (protein specific)
Specific Activity [micromol/min/mg] (protein specific)
Storage Stability (protein specific)
Substrates and Products (Substrate) (protein specific)
Subunits (protein specific)
Temperature Optimum [°C] (protein specific)
Temperature Range [°C] (protein specific)
Temperature Stability [°C] (protein specific)
Turnover Number [1/s] (protein specific)
pH Optimum (protein specific)
pH Range (protein specific)
pH Stability (protein specific)
pI Value (protein specific)
Expression
General Information
General Information (protein specific)
Expression (protein specific)
KCat/KM [mM/s]
KCat/KM [mM/s] (protein specific)
739115
Harazi
The interaction of UDP-N-acety ...
Homo sapiens
Mol. Neurobiol.
54
2928-2938
2017
-
-
1
-
1
-
-
-
-
-
-
1
-
1
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
1
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
739177
Liu
Muscle biopsy and UDP-N-acetyl ...
Homo sapiens
NeuroReport
26
598-601
2015
-
-
-
-
2
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
2
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
739729
Hinderlich
-
UDP-GlcNAc 2-epimerase/ManNAc ...
Homo sapiens
Top. Curr. Chem.
366
97-138
2015
-
-
-
-
2
-
1
-
-
1
-
1
-
1
-
-
-
-
-
-
-
-
1
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
2
-
-
1
-
-
-
1
-
1
-
-
-
-
-
-
-
-
1
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
728341
Grover
Role of UDP-N-acetylglucosamin ...
Homo sapiens
Mol. Neurobiol.
50
257-273
2014
-
-
-
-
2
-
-
-
3
-
-
1
-
1
-
-
-
-
-
1
-
-
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
2
-
-
-
-
-
3
-
-
1
-
-
-
-
-
1
-
-
1
-
-
-
-
-
-
-
-
-
-
1
1
-
-
-
737385
North
Cloning, expression, purificat ...
Staphylococcus aureus, Staphylococcus aureus USA300
Acta Crystallogr. Sect. F
70
643-649
2014
-
-
1
1
-
-
-
-
-
-
1
2
-
8
-
-
1
-
-
-
-
-
2
1
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
1
-
-
-
-
-
-
-
-
1
2
-
-
-
1
-
-
-
-
2
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
722375
Yardeni
Murine isoforms of UDP-GlcNAc ...
Mus musculus
Glycoconj. J.
30
609-618
2013
-
-
1
-
2
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
2
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
-
4
4
-
-
-
722220
Kemmner
Loss of UDP-N-acetylglucosamin ...
Homo sapiens
FASEB J.
26
938-946
2012
-
-
-
-
1
-
-
-
-
-
-
-
-
2
-
-
-
-
-
3
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
3
-
-
-
-
-
-
-
-
-
-
-
-
1
3
3
1
-
-
722749
Martinez
Crystal structures of N-acetyl ...
Homo sapiens
J. Biol. Chem.
287
13656-13665
2012
-
-
-
1
2
-
3
2
1
1
-
1
-
2
-
-
-
-
-
-
1
-
1
-
1
-
-
-
1
-
-
1
-
-
-
-
-
-
1
1
2
-
-
3
-
2
1
1
-
1
-
-
-
-
-
-
1
-
1
-
1
-
-
-
1
-
-
-
-
2
2
-
-
-
723028
Mori-Yoshimura
Heterozygous UDP-GlcNAc 2-epim ...
Homo sapiens
J. Neurol. Sci.
318
100-105
2012
-
-
-
-
4
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
4
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
1
-
-
-
716189
Moeller
Efficient metabolic oligosacch ...
Homo sapiens
Mol. Biosyst.
7
2245-2251
2011
-
1
1
-
1
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
1
-
-
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
2
2
-
-
-
721653
Yardeni
Identification, tissue distrib ...
Homo sapiens
Biochemistry
50
8914-8925
2011
-
-
1
-
-
-
-
-
1
1
-
2
-
1
-
-
-
-
-
-
-
-
2
1
-
-
-
-
-
-
-
1
-
-
-
-
-
1
1
-
-
-
-
-
-
-
1
1
-
2
-
-
-
-
-
-
-
-
2
1
-
-
-
-
-
-
-
-
-
3
3
-
-
-
706438
Tong
Crystal structure of the N-ace ...
Homo sapiens
PLoS ONE
4
e7165
2009
-
-
1
1
-
-
-
-
-
-
-
-
-
2
-
-
1
-
-
-
-
-
-
2
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
1
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
-
-
-
2
-
-
-
-
-
-
-
-
-
2
2
-
-
-
694815
Amsili
UDP-N-acetylglucosamine 2-epim ...
Homo sapiens
PLoS ONE
3
e2477
2008
-
1
1
-
-
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
-
-
-
-
1
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
705073
Ishihara
UDP-N-acetylglucosamine 2-epim ...
Homo sapiens
J. Med. Dent. Sci.
55
181-187
2008
-
-
-
-
-
-
-
-
3
-
1
-
-
1
-
-
-
-
-
1
-
-
-
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
3
-
1
-
-
-
-
-
-
1
-
-
-
1
-
-
-
-
-
-
-
-
-
2
2
-
-
-
673693
Reinke
Prediction of three different ...
Homo sapiens
FEBS Lett.
581
3327-3331
2007
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
-
-
-
7
-
-
3
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
14
-
-
3
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
673699
Bork
Enhanced sialylation of EPO by ...
Rattus norvegicus
FEBS Lett.
581
4195-4198
2007
-
-
1
-
-
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
673900
Gagiannis
Reduced sialylation status in ...
Mus musculus
Glycoconj. J.
24
125-130
2007
-
-
-
-
1
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
675445
Ghaderi
Evidence for dynamic interplay ...
Rattus norvegicus
J. Mol. Biol.
369
746-758
2007
-
-
1
-
-
-
-
-
1
-
4
-
-
1
-
-
1
-
-
1
-
-
1
1
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
1
-
4
-
-
-
-
1
-
1
-
-
1
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
672131
Penner
Influence of UDP-GlcNAc 2-epim ...
Homo sapiens
Biochemistry
45
2968-2977
2006
-
-
1
-
23
-
-
-
-
-
-
-
-
1
-
-
1
-
-
-
-
-
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
23
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
-
-
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
673676
Weidemann
The collapsin response mediato ...
Rattus norvegicus
FEBS Lett.
580
6649-6654
2006
-
-
1
-
-
-
-
-
-
-
-
-
-
1
-
-
-
-
-
1
-
-
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
674638
Wang
Roles for UDP-GlcNAc 2-epimera ...
Homo sapiens
J. Biol. Chem.
281
27016-27028
2006
-
-
1
-
-
-
-
-
-
-
-
-
-
2
-
-
-
-
-
1
-
-
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
661666
Krause
Localization of UDP-GlcNAc 2-e ...
Homo sapiens, Mus musculus
Exp. Cell Res.
304
365-379
2005
-
-
1
-
-
-
-
-
4
-
2
2
-
2
-
-
-
-
-
13
-
-
4
2
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
4
-
2
2
-
-
-
-
-
13
-
-
4
2
-
-
-
-
-
-
-
-
-
-
-
-
-
-
661840
Sparks
Use of a cell-free system to d ...
Homo sapiens
Glycobiology
15
1102-1110
2005
-
-
-
-
1
-
-
-
1
-
-
1
-
2
-
-
-
-
-
1
-
-
2
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
-
-
-
1
-
-
1
-
-
-
-
-
1
-
-
2
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
660988
Blume
Domain-specific characteristic ...
Rattus norvegicus
Biochem. J.
384
599-607
2004
-
-
1
-
8
-
-
-
-
-
2
1
-
1
-
-
-
-
-
-
-
-
2
2
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
8
-
-
-
-
-
-
-
2
1
-
-
-
-
-
-
-
-
2
2
-
-
-
-
-
-
-
-
-
-
-
-
-
-
661735
Hinderlich
The homozygous M712T mutation ...
Homo sapiens
FEBS Lett.
566
105-109
2004
-
-
1
-
1
-
-
-
-
-
1
1
-
2
-
-
1
-
-
1
-
1
2
1
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
1
-
-
-
-
-
-
-
1
1
-
-
-
1
-
1
-
1
2
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
662186
Noguchi
Reduction of UDP-N-acetylgluco ...
Homo sapiens
J. Biol. Chem.
279
11402-11407
2004
-
-
1
-
1
-
-
-
-
-
-
1
-
1
-
-
1
-
-
-
-
-
2
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
1
-
-
-
-
-
-
-
-
1
-
-
-
1
-
-
-
-
2
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
663299
Blume
UDP-N-acetylglucosamine 2-epim ...
Rattus norvegicus
Protein Expr. Purif.
35
387-396
2004
-
-
1
-
-
-
-
-
-
-
1
1
-
1
-
-
1
-
-
1
1
1
2
1
-
-
-
-
-
-
2
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
-
-
1
1
-
-
-
1
-
1
1
1
2
1
-
-
-
-
-
-
2
-
-
-
-
-
-
-
641701
Hinderlich
Molecular cloning and characte ...
Homo sapiens, Mus musculus
Eur. J. Biochem.
267
3301-3308
2000
-
-
2
-
-
-
-
-
-
-
2
-
-
6
-
-
-
-
-
1
-
-
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
2
-
-
-
-
-
-
-
-
-
-
2
-
-
-
-
-
-
1
-
-
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
641739
Effertz
Selective loss of either the e ...
Rattus norvegicus
J. Biol. Chem.
274
28771-28778
1999
-
-
1
-
9
-
-
-
1
-
2
1
-
1
-
-
-
-
-
1
1
-
2
2
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
9
-
-
-
-
-
1
-
2
1
-
-
-
-
-
1
1
-
2
2
-
-
-
-
-
-
-
-
-
-
-
-
-
-
641740
Horstkorte
Tissue expression and amino ac ...
Mus musculus, Mus musculus NMRI, Rattus norvegicus, Rattus norvegicus Wistar
Eur. J. Biochem.
260
923-927
1999
-
-
1
-
-
-
-
-
-
-
2
3
-
168
-
-
-
-
-
7
-
-
9
2
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
-
-
2
3
-
-
-
-
-
7
-
-
9
2
-
-
-
-
-
-
-
-
-
-
-
-
-
-
641741
Lucka
Primary structure and expressi ...
Homo sapiens
FEBS Lett.
454
341-344
1999
-
1
1
-
-
-
-
-
-
-
1
-
-
1
-
-
-
-
-
5
-
-
1
2
-
-
-
-
-
-
-
-
-
-
-
-
1
1
-
-
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
5
-
-
1
2
-
-
-
-
-
-
-
-
-
-
-
-
-
-
641700
Hinderlich
Purification and characterizat ...
Rattus norvegicus
Eur. J. Biochem.
252
133-139
1998
-
-
-
-
-
-
6
-
-
-
-
1
-
1
-
-
1
-
-
1
-
-
2
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
6
-
-
-
-
-
1
-
-
-
1
-
1
-
-
2
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
641738
Hinderlich
Metal ion requirement of bifun ...
Rattus norvegicus
BioMetals
11
253-258
1998
1
-
-
-
-
-
-
-
-
4
-
1
-
2
-
-
1
-
-
1
-
-
3
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
-
-
-
4
-
1
-
-
-
1
-
1
-
-
3
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
2280
Hinderlich
A bifunctional enzyme catalyze ...
Rattus norvegicus, Rattus norvegicus Wistar
J. Biol. Chem.
272
24313-24318
1997
-
-
-
-
-
1
-
4
1
-
3
2
-
167
-
-
1
-
-
3
1
1
6
2
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
-
4
1
-
3
2
-
-
-
1
-
3
1
1
6
2
-
-
-
-
-
-
-
-
-
-
-
-
-
-
641735
Zeitler
Inhibition of N-acetylglucosam ...
Homo sapiens, Rattus norvegicus, Rattus norvegicus Wistar
Eur. J. Biochem.
204
1165-1168
1992
-
-
-
-
-
-
1
-
-
-
-
3
-
169
-
-
-
-
-
2
-
-
6
-
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
-
-
1
1
-
-
-
-
3
-
-
-
-
-
2
-
-
6
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
2269
Van Rinsum
Subcellular localization and t ...
Rattus norvegicus, Rattus norvegicus Wistar
Biochem. J.
210
21-28
1983
-
-
-
-
-
-
-
-
2
-
-
2
-
167
-
-
-
-
-
6
-
-
4
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
2
-
-
2
-
-
-
-
-
6
-
-
4
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
135465
Corfield
-
Changes in the activity of the ...
Rattus norvegicus, Rattus norvegicus Sprague-Dawley
Biochem. Soc. Trans.
11
766-767
1983
-
-
-
-
-
-
-
-
-
-
-
2
-
162
-
-
-
-
-
1
-
-
4
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
2
-
-
-
-
-
1
-
-
4
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
641732
Banerjee
-
N-Acetylmannosamnine kinase ...
Salmonella enterica subsp. enterica serovar Typhimurium, Salmonella enterica subsp. enterica serovar Typhimurium LT2
Methods Enzymol.
42c
53-58
1975
-
-
-
-
-
1
-
2
-
4
-
2
-
42
-
-
1
-
-
-
1
1
6
-
-
-
-
-
1
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
-
2
-
4
-
2
-
-
-
1
-
-
1
1
6
-
-
-
-
-
1
-
-
-
-
-
-
-
-
-
641731
Banerjee
Purification and properties of ...
Escherichia coli, Escherichia coli B / ATCC 11303, Salmonella enterica subsp. enterica serovar Typhimurium, Staphylococcus aureus
Eur. J. Biochem.
8
200-206
1969
-
-
-
-
-
1
1
2
-
4
-
4
-
180
-
-
1
-
-
-
1
1
9
-
-
-
1
-
2
-
-
-
-
-
-
-
-
-
-
-
-
1
-
1
-
2
-
4
-
4
-
-
-
1
-
-
1
1
9
-
-
-
1
-
2
-
-
-
-
-
-
-
-
-
641730
Kundig
The sialic acids. VII. N-acyl- ...
Rattus norvegicus
J. Biol. Chem.
241
5619-5626
1966
-
-
-
-
-
1
-
3
-
1
-
1
-
2
-
-
1
-
-
5
3
1
4
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
-
3
-
1
-
1
-
-
-
1
-
5
3
1
4
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
641729
Ghosh
Enzymatic phosphorylation of N ...
Rattus norvegicus
Biochemistry
47
955-958
1961
-
-
-
-
-
-
-
-
-
-
-
1
-
1
-
-
1
-
-
1
1
-
3
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
-
1
-
1
1
-
3
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-